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Abstract
Objective: To assess the performance of a test for breast cancer utilizing synchrotron x-ray diffraction analysis of scalp hair from 
women undergoing diagnostic radiology assessment.
Design and Setting: A double-blinded clinical trial of women who attended diagnostic radiology clinics in Australia.
Patients: 1796 women referred for diagnostic radiology, with no previous history of cancer.
Main Outcome Measures: Sensitivity, specificity and accuracy of the hair test analysis compared to the gold standard of imaging 
followed by biopsy where indicated.
Results: The hair-based assay had an overall accuracy of 77% and a negative predictive value of 99%. For all women, the 
sensitivity of both mammography and x-ray diffraction alone was 64%, but when used together the sensitivity rose to 86%. The 
sensitivity of the hair test for women under the age of 70 was 74%.
Conclusion: In this large population trial the association between the presence of breast cancer and an altered hair fibre X-ray diffraction 
pattern previously reported has been confirmed. It appears that mammography and X-ray diffraction of hair detect different populations 
of breast cancers, and are synergistic when used together.
Keywords: x-ray diffraction, hair, breast cancer, randomized clinical trial, synchrotronCorino et al
84  Breast Cancer: Basic and Clinical Research 2009:3
Introduction
There has been a long-term focus on developing 
methods for early stage detection of cancer in order to 
maximize treatment outcomes. Breast cancer is one 
example that clearly demonstrates excellent survival 
statistics  when  early-stage  disease  is  treated  using 
current therapies. If all cases of breast cancer could 
be detected prior to metastasis then there would be 
a significant reduction of both individual mortality 
and the economic burden on the community.1 Newer 
diagnostic  methods  which  enhance  sensitivity  and 
specificity of current screening modalities are clearly 
needed to identify women with early stage disease 
and to supplement the proven role of mammography 
and breast ultrasound.
There is a recognized association between a per-
son’s overall health and the state of their hair and 
nails.2 Abnormalities in hair and nails can result from 
alterations in nutrient supply, inflammation, toxins, 
heavy metals and physical damage. Many of these 
may be affected by a systemic disease or by a local-
ized malignancy through mechanisms yet to be fully 
understood.2 It is becoming more apparent that hair 
fibre production is the result of a complex relation-
ship between the follicle and its local environment 
and systemic factors.3 It can therefore be said that the 
end of the fibre closest to the follicle is most likely to 
represent the current state of the individual’s health.
The structural arrangement of keratin intermediate 
filaments in the hair fibre can be determined using 
x-ray diffraction. Astbury used x-rays to demonstrate 
that  hair  contains  a  crystalline  phase,4,5  and  Paul-
ing  proposed  the  alpha-helical  secondary  structure 
of hair to account for the resulting x-ray diffraction 
patterns.6
In 1999 James and colleagues reported differences 
in the small angle x-ray scattering (SAxS) patterns 
of hair from individuals with breast cancer compared 
to healthy subjects.7 The SAxS patterns of hair from 
cancer  patients  contained  a  ring  of  comparatively 
low intensity which was superimposed on the normal 
α-keratin pattern obtained from healthy control sub-
jects. Subsequent papers from the same group reported 
SAxS  analysis  results  of  blinded  human  samples 
which were consistent with the initial publication.8,9 
Pre-clinical data supporting the finding was presented 
using an animal model of breast cancer.9
A study of hairs from cancer and normal subjects 
using  Fourier  transform  infrared  attenuated  total 
reflection  provided  independent  validation  of  the 
underlying hypothesis that hair from individuals with 
breast cancer exhibits structural and compositional 
abnormalities.10
In 2008, the first replication of the finding inde-
pendent of the original author was reported by two 
of the present authors.11 They reported the results of 
analysis of hair from 39 women, 15 of whom had 
confirmed breast cancer. They achieved a sensitivity 
of 86% and a specificity of 81%. The results were less 
accurate than reported by James7–9 but they confirmed 
an association between the appearance of a ring with a 
molecular spacing (determined to be 4.76 ± 0.07 nm) 
and the presence of breast cancer.
Some key questions remain to be resolved. For 
example, it is unclear from the literature whether any 
of breast cancer patients were undergoing chemother-
apy at the time of hair collection. As chemotherapy 
alters hair and nail growth this could be an impor-
tant consideration. To address this issue, this study 
collected hair from women with no history of cancer 
of any sort, and prior to a diagnosis of breast can-
cer being made. A second key question is what is the 
sensitivity and specificity of the assay in a large pop-
ulation of women presenting for diagnostic screen-
ing. This paper reports on the results of a multi-site 
blinded clinical trial which was undertaken to address 
these questions.
Material and Methods
study design
The primary aim of the double-blind study was to 
determine the accuracy (sensitivity and specificity) of 
using synchrotron-derived x-ray diffraction of hair 
to detect the presence of invasive breast cancer by 
reference to the gold standard of imaging (mammog-
raphy and/or ultrasound) followed by biopsy where 
indicated in a diagnostic population. Sensitivity was 
defined as the proportion of all cancers (confirmed 
by biopsy) that exhibited an x-ray diffraction pat-
tern that contained a circular feature reported to be 
associated with breast cancer and specificity as the 
proportion of all patients that were negative either by 
imaging or by biopsy that gave a normal x-ray dif-
fraction pattern.hair and breast cancer
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sample collection and handling
Hair samples were collected from women referred 
to  one  of  several  radiology  clinics  for  a  diagnos-
tic examination. This population was chosen rather 
than a screening population in order to increase the 
number of cancer cases in the study. Women were 
recruited to the trial if they were willing and able to 
provide informed consent and had usable scalp hair at 
least 30 mm in length. Women were excluded if their 
scalp hair had been dyed or chemically treated (such 
as permanent waving) within the previous 4–6 weeks 
or if they had a history of breast cancer or other can-
cers (excluding non-melanoma skin cancer and cervi-
cal intra-epithelial neoplasia) within 5 years, ensuring 
that they were not undertaking chemotherapy treat-
ment at time of hair collection. Recruitment was self-
selecting – as women arrived at the clinic they were 
provided with information, and if they were willing 
to take part and met the criteria, they were recruited, 
regardless of any other factors.
Scalp hairs (approximately 20) were cut from the 
region behind the ear, as close to the skin as pos-
sible. Recruitment and sample collection were done 
by a registered nurse who had been trained in Good 
Clinical Practice. All hair samples were stored in pur-
pose built plastic specimen containers. Samples were 
assigned a unique identifying number (barcode) at the 
clinic and then supplied for diffraction analysis with 
no other identifying information. All patient medical 
histories were kept on file at the clinic.
x-ray diffraction assessment required the analysis 
of six individual hair fibres. They were loaded onto 
specially designed sample holders and transported to 
the synchrotron by specialist courier (World Courier, 
Sydney, Australia).
synchrotron X-ray diffraction
Synchrotron x-ray diffraction experiments were car-
ried out at the Advanced Photon Source at the Argonne 
National Laboratory, USA. Analyses were conducted 
at sector 31ID (SGx-CAT).
The wavelength of x-rays used for the diffraction 
studies was 1.1168Å and had a resolution (∆E/E) of 
1 × 10-4. The sample to detector distance was approx-
imately 1 metre and was under vacuum to reduce 
background noise due to air-scattered X-rays. System 
calibration was achieved using the scattering pattern 
of Silver Behenate.12 The beam spot was defined by 
slits (JJX-ray Denmark) and was 85 µm in the verti-
cal and 300 µm in the horizontal. Each sample was 
exposed to approximately 1 × 1014 photons. The resul-
tant diffraction patterns were collected on a MAR165 
CCD detector (www.rayonix.com).
image analysis
Hair fibre diffraction patterns were analysed using 
Saxs15ID13 as previously described.11
statistical analysis
Calls of “positive” or “negative” based on the x-ray 
diffraction images were made by two analysts blinded 
to the clinical status of the patient. A negative call was 
defined as a sample that exhibited the standard alpha-
keratin reflections and did not have an additional cir-
cular feature superimposed on the pattern. A negative 
control (a hair fibre from a woman without breast 
cancer  as  confirmed  by  mammography)  was  used 
(Fig. 1A). A positive sample was one in which the 
alpha-keratin  reflections  were  present  along  with 
a circular feature11 at a q space of 1.32 ± 0.02 nm-1 
(Fig. 1B). One-dimensional data was extracted from 
each x-ray diffraction pattern to determine the exact 
spacing of features in the pattern. The intensity data 
along a single line starting from the centre of the pat-
tern along the meridional plane at 60°, 120°, 240° 
and  300°,  as  previously  described.11  This  process 
was used to ensure that if a ring was present in the 
x-ray  diffraction  pattern,  the  intensity  data  would 
confirm that it was located at the defined q space and 
was present in all four quadrants. Through analysis 
of this data, the circular nature of the ring could be 
established.
The analysts made calls independently and where 
there was disagreement, they discussed the patterns 
and made a consensus call. Six hairs were analysed 
for each subject and a minimum of two hairs dis-
playing the characteristic ring in the zone of interest 
were required for a sample to be called “positive”. 
The results of the imaging were re-analysed by two 
independent  radiologists  under  the  supervision  of 
an independent auditor. The pathology results (fol-
lowing biopsy) were also forwarded to the auditor. 
The diffraction analyses were separately forwarded 
to the independent auditor, who de-coded the results, Corino et al
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matched the imaging and pathology results with the 
x-ray diffraction data, and communicated the results 
to the investigators. Sensitivity, specificity, accuracy, 
positive and negative predictive values and likelihood 
ratios were calculated using standard definitions.14
Microscopic examination of hairs
To  gain  a  greater  understanding  of  the  impact  of 
certain  physical  characteristics  of  the  hair  fibres 
(diameter, medulla and surface contamination) on the 
x-ray diffraction patterns, samples were examined by 
bright field light microscopy.
Results
Collection of samples
Scalp hair samples from 1796 women were analysed. 
The average age of the participants was 52, and 80% 
were  Caucasian  (Table  1). There  were  no  adverse 
events involved in the collection of samples.
X-ray diffraction patterns
Examples of positive and negative X-ray diffraction 
patterns are shown at Figure 1. Figure 1A is a repre-
sentative example of an x-ray diffraction pattern of 
a hair fibre, from a woman confirmed negative for 
breast  cancer  by  mammography.  The  image  was 
processed using SAxS15ID software. The primary 
alpha-keratin features present along the meridional 
axis are the 7th order peak (q = 0.94 nm-1), the 19th 
order peak (q = 2.54 nm-1) and the 38th order peak 
(q = 5.08 nm-1) of the 46.7 nm lattice. Also seen in 
the pattern are other features along the meridional 
axis  known  to  be  present  in  the  X-ray  diffraction 
pattern of hair. The region at centre of the diffraction 
pattern is shielded from the direct beam by a lead beam 
stop and therefore has not been exposed to x-rays. 
During image processing this produces an artefactual 
feature in the centre of the diffraction pattern but has 
no impact on the region containing the breast cancer 
ring. The one dimensional plot confirms that there is 
no peak of intensity present in the image.
In contrast, an x-ray diffraction pattern of a hair 
from an individual with breast cancer is shown in 
Figure 1B, along with the one-dimensional plot. Note 
that all the features seen in Figure 1A are present in 
Figure 1B with the only difference being the superim-
position of a circular feature at a q space of 1.32 nm-1 
as confirmed by the plot.
statistical analysis
Overall analysis
The data for the full population is shown at Table 2. 
Of the 1796 patients, 1775 women in the study had 
Table 1. ethnicity of trial participants.
ethnic group percentage
Aboriginal/Tsi 0.3
African 0.3
Asian 3.6
hispanic 0.3
Middle eastern 1.6
Pacific Islander 0.3
south/Central American 0.3
Caucasian/european 80.1
Not specified 13.3
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Figure  1.  examples  of  “positive”  (for  breast  cancer)  and  “negative” 
(for breast cancer) hair fibre X-ray diffraction patterns. The raw diffrac-
tion data was processed and resulting images were generated using 
sAXs-15iD as described in the text. A) the pattern from a “negative” 
hair  fibre.  No  circular  feature  is  present,  as  confirmed  by  the  plot. 
note the presence of intense arcs, particularly in the equatorial plane. 
These are diffraction features regularly observed for α-keratin. B) the 
pattern produced from a hair fibre from a woman with breast cancer. 
note  the  circular  feature  (arrowed)  passing  through  the  equatorial 
spots, at a q space of 1.32 nm-1 as defined by the accompanying one-
dimensional  plot.  The  other  α-keratin  features  are  present  at  similar 
intensities to those observed in A.hair and breast cancer
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mammographic examination alone or in combination 
with ultrasound. 1341 had both ultrasound and mam-
mography.  21  of  the  women  had  no  mammogram 
result recorded. 197 (11%) were sent for biopsy as a 
result of a suspicious imaging examination. 39 patients 
of the 197 that underwent biopsy (19.8%) were con-
firmed to have invasive breast cancer. The average 
age of these women was 55 years. 25 of the 39 con-
firmed breast cancer positives (64%) had a positive 
x-ray diffraction pattern. Of the 1757 patients with 
no detectable breast cancer either by biopsy or imag-
ing alone, 394 (22%) had a positive x-ray diffraction 
pattern. 158 patients (80%) of the 197 who underwent 
biopsy returned a negative pathology result. Of these, 
134 (85%) were negative by x-ray diffraction.
Chi-squared test
The  observed  number  of  breast  cancer  positives 
with a ring was 25, in comparison to an expected 
number  of  9.  The  difference  was  significant: 
χ² (1, N = 1796) = 37.79, p  0.001.
Odds ratio
The OR of breast cancer patients having a positive 
diffraction test using the data in Table 2 is 6.1775, 
with 95% CIs 3.5388 to 10.7837.
Analysis by age
Breast cancer patients whose hair x-ray diffraction 
pattern did not display a ring had an average age of 
64.5 years, whilst those with a ring had an average 
age of 54.8 years. The ability to detect the presence of 
invasive breast cancer using x-ray diffraction of hair 
declined significantly for patients over the age of 69 
(Fig. 2). When the data were re-analysed excluding 
women over 69 years of age, there were 27 women 
with  confirmed  invasive  breast  cancer,  of  whom 
20 (74%) were detected using hair x-ray diffraction. 
The percentage of false positives remained similar 
to the overall analysis, although for women of any 
age who were confirmed negative for invasive breast 
cancer by biopsy, the false positive rate was much 
lower (24 of 158 patients, 15%).
The calculated statistics for both groups are shown 
in Table 3. Overall the hair diffraction test had an 
accuracy of 77%, with a sensitivity of 64% for all 
women which increased to 74% for women under 
70 years of age. It also had a high negative predic-
tive value as demonstrated by the degree of accuracy 
(85%) with which the test was able to detect a con-
firmed negative biopsy as negative.
When reviewing the mammographic data in the 
absence of ultrasound testing, 22 of the 39 cancers gave 
mammograms that were indicative of the presence 
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Figure 2. Analysis of the effect of age on the sensitivity, specificity and 
accuracy of using X-ray diffraction of hair to detect the presence of breast 
cancer.
Table 2. Overall results.
patients 
with 
breast 
cancer 
confirmed 
by biopsy
patients without 
breast cancer
Total
Confirmed 
by biopsy
negative 
by imaging
Ring 25 (64%) 24 (15%) 370 (23%) 419 (23%)
no ring 14 (36%) 134 (85%) 1229 (77%) 1377 (77%)
Total 39 158 1599 1796
Table 3. statistical characteristics of the X-ray diffraction 
test.
Feature All 
participants 
(n = 1796)
participants 
aged  70 
(n = 1627)
sensitivity 64% 74%
Specificity 77.6% 78%
Positive predictive value 6% 5.4%
negative predictive value 99% 99.4%
Accuracy 77.3% 77.9%
Likelihood ratio of a  
positive test
2.8 3.3
Likelihood ratio of a 
negative test
0.05 0.3Corino et al
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of breast cancer, with one or more features such as 
stellate shape, calcifications, speculations and archi-
tectural distortions. One of the cancer patients did not 
have a mammogram. The other 16 were normal or 
appeared equivocal. The hair test detected 25 cancers 
as positive. 33 cancers were positive by either mam-
mography alone or the hair xRD test (Table 4).
Microscopic examination of hairs
Hair  fibres  from  false  positive  samples  and  true 
negative samples were retrospectively examined for 
the presence of medullas and surface contaminants, 
which have the potential to affect the normal alpha-
keratin X-ray diffraction pattern of hair. The false 
positive samples had significantly more fibres with 
either medullas or surface particles than the true neg-
ative samples. The average diameter of hairs overall 
was 68 microns. Hair fibres from younger women 
had  only  a  slightly  (10%)  larger  diameter  than 
that of women over 65 years of age. There was no 
significant difference in diameter between older and 
younger fibres in false positives and true negatives 
(Table 5).
Discussion
This study was undertaken to compare the results of 
standard imaging (mammography and/or ultrasound) 
in detecting cancer in patients undergoing diagnostic 
imaging with changes in hair structure using x-ray 
diffraction.  The  detection  rate  of  cancer  by  imag-
ing in this series was 39/1796 or 2.17%. This value 
is consistent with a clinical series self-referring for 
symptoms and/or self selected for personal high risk, 
particularly  considering  the  average  age  which  is 
younger than screening populations (50–69).
The overall specificity of X-ray diffraction analysis 
of  hair  to  detect  breast  cancer  was  77%  for  this 
population. This equates to a false positive detection 
rate of 22%. A second smaller trial in a similar patient 
population (213 women) conducted at the same time 
in a hospital-based clinic showed a similar specificity 
(78%) (data not shown). The results presented in this 
study and their statistical analysis support the previ-
ously reported correlation between an altered x-ray 
diffraction pattern of hair and the presence of breast 
cancer.7–9,11
The data indicate that age is a key factor in determ-
ining the accuracy of the test, with sensitivity declin-
ing from 80% in women 40 years of age and younger, 
to around 40% in women over 69 years of age. The 
reason for this is not known.
Apart from age, there did not appear to be any 
significant  correlation  between  the  usual  clinical 
prognostic markers (tumour size, grade, presence of 
calcifications,  hormone  receptors)  in  those  cancers 
detected by x-ray diffraction and those that x-ray 
diffraction failed to detect. Two of the patients with 
breast cancer only had ultrasound examination (no 
mammography). They were both positive by the hair 
test. There are several potential mechanisms which 
could explain the data, and go beyond a simple cor-
relation between a single characteristic of a tumour 
and the presence of a ring in the x-ray diffraction 
pattern.  One  is  the  possibility  of  incorporation  of 
extraneous material into the fibre. Increased lipid has 
Table  4.  effect  of  combining  mammography  and  X-ray 
diffraction on detection of breast cancer.
cancers 
detected
sensitivity
Mammography alone 22 61%
XRD alone 25 64%
Mammograpy and/or XRD 33 85%
Table 5. Comparison of microscopic hair characteristics 
between false positives and true negatives.
False pos True neg p value
Number of fibres 
analysed
2274 2718
Percentage of 
samples with at least 
one medullated fibre
71.8% 58.1%
Average no. of 
medullated fibres per 
sample
2.1 1.5 0.0001
Percentage of 
samples with at least 
one hair displaying 
surface contaminants
29.0% 12.4%
Average no. of 
fibres with surface 
contaminants per 
sample
0.7 0.3 0.0001
  Mean diameter  55 72 69 0.129
  Mean diameter  65 71 65 0.161hair and breast cancer
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been identified in hairs from breast cancer patients.10 
Another  possibility  is  that  secreted  cytokines  and 
growth  factors  from  the  localised  tumour  either 
directly affect the function of hair follicles in laying 
down keratin intermediate filaments, or affect them 
indirectly via induction of a host response.
It is important to place this study in the context of 
the gold standard for screening—mammography. In 
a 2001 review of historical mammography screening 
trials,15  sensitivity  for  mammograms  alone  ranged 
from 39 to 92%. However, most sensitivity determinat-
ions were in the range of 60–66% overall, with Malmo 
at  61%,  Edinburgh  63%,  CNBSS-1  (ages  40–49) 
61%,  and  CNBSS-2  (ages  50–59)  66%. These  low 
sensitivity values have been attributed to the fact that 
most of these trials began many years ago and that 
mammographic  quality  and  technology  has  vastly 
improved. However, A 2007 study in Tochigi, Japan 
gave  a  sensitivity  for  mammography  of  61.5%.16 
Furthermore, using the most advanced technology in 
the recent Digital Mammographic Imaging Screening 
Trial (DMIST) coordinated by the American College 
of Radiology,17 the overall sensitivity as defined by a 
12-month follow-up period revealed only 70% sensiti-
vity with digital technology and 66% for state-of-the-art 
film screen technology, comparable to the sensitivi-
ties in the other trials. Based on 15-month follow-up, 
under the assumption that a cancer discovered within a 
15-month time frame following a negative mammogram 
was likely to have been present on the prior study, 
mammographic sensitivity under this definition was 
only 41%, and the difference between digital technol-
ogy and film screen disappeared entirely.
It appears that not all patients with invasive breast 
cancer exhibit the change in their hair fibres. This is 
perhaps not surprising. It has been noted that breast 
cancer is a complex and heterogeneous disease, and 
that no single model or biological source is expected 
to mimic all aspects of the disease.18 For example, 
using magnetic resonance spectroscopy, it has been 
demonstrated that only 80% of breast cancers have 
a  specific  membrane  signature.19  The  accuracy  of 
the assay is also affected by variability in the quality 
and biological characteristics of the hair sample. The 
presence of medullas may underlie some of the false 
positives. It is known that various cosmetic hair treat-
ments affect the ultrastructure of hair. This in turn can 
have a significant impact on the efficacy of the hair 
diffraction test. In order to collect optimal samples for 
diffraction analysis, donors should defer such chemi-
cal interventions for at least four weeks prior provid-
ing their sample. This would allow adequate time for 
the growth of an untreated segment of hair (approxi-
mately 1 cm) and therefore facilitate the diffraction 
analysis to be conducted on unmodified material.
The estimates of sensitivity and specificity reported 
here for the hair test are based on the current screen-
ing reference standard (imaging with biopsy for posit-
ive  and  equivocal  imaging  results)  and  no  further 
testing for the negative imaging results. In so far as 
the reference standard represents current best prac-
tice, the data collected provide information about the 
extent to which the hair test meets this standard. Its 
main limitation is in identifying the true sensitivity of 
the hair test if it was in fact more sensitive than cur-
rent best practice (fewer false positives). The authors 
recognise that this may not reflect the ‘true’ accuracy 
of the hair test in the absence of follow-up data on 
imaging negatives. A follow-up study on a subset of 
the patients is being undertaken.
This study however demonstrates that the hair test 
and mammography detect different but overlapping 
populations of breast cancers, and thus the hair test 
may represent a useful adjunct in the diagnosis and 
even follow up process in the patient with breast can-
cer but is not a replacement for standard breast imag-
ing at this point. It is hoped that further studies will 
elucidate the molecular mechanisms which give rise 
to the ring pattern in breast cancer.
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